NYSE:FMS Fresenius Medical Care AG & Co. KGaA Q3 2025 Earnings Report $27.14 +0.08 (+0.28%) As of 02:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. ProfileEarnings HistoryForecast Fresenius Medical Care AG & Co. KGaA EPS ResultsActual EPSN/AConsensus EPS $0.58Beat/MissN/AOne Year Ago EPSN/AFresenius Medical Care AG & Co. KGaA Revenue ResultsActual RevenueN/AExpected Revenue$4.72 billionBeat/MissN/AYoY Revenue GrowthN/AFresenius Medical Care AG & Co. KGaA Announcement DetailsQuarterQ3 2025Date11/4/2025TimeBefore Market OpensConference Call DateTuesday, November 4, 2025Conference Call Time6:00AM ETConference Call ResourcesEarnings HistoryCompany Profile Fresenius Medical Care AG & Co. KGaA Earnings HeadlinesFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Upgraded by Weiss Ratings to "Buy (B-)" RatingOctober 9 at 2:21 AM | americanbankingnews.comFresenius Medical Care appoints Joseph Turk as new Management Board Member for Care EnablementOctober 1, 2025 | prnewswire.comTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…October 9 at 2:00 AM | Brownstone Research (Ad)Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segmentSeptember 18, 2025 | prnewswire.comUBS Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)August 24, 2025 | theglobeandmail.comFresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation frameworkAugust 11, 2025 | prnewswire.comSee More Fresenius Medical Care AG & Co. KGaA Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Fresenius Medical Care AG & Co. KGaA? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fresenius Medical Care AG & Co. KGaA and other key companies, straight to your email. Email Address About Fresenius Medical Care AG & Co. KGaAFresenius Medical Care AG & Co. KGaA (NYSE:FMS) is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services. In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines. These offerings are complemented by a range of pharmaceuticals, including anticoagulants and iron therapies, along with digital health solutions for remote patient monitoring and data management. By integrating clinical expertise with proprietary technology, Fresenius Medical Care aims to improve treatment outcomes and enhance patient quality of life. Founded in 1996 as a spin‐off from the Fresenius SE healthcare group, Fresenius Medical Care is headquartered in Bad Homburg, Germany. The company maintains a presence in over 50 countries across North America, Europe, Latin America and the Asia Pacific region. Its global reach is supported by manufacturing facilities, research centers and a network of more than 4,000 dialysis clinics, serving hundreds of thousands of patients worldwide.View Fresenius Medical Care AG & Co. KGaA ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 Earnings Upcoming Earnings Fastenal (10/13/2025)BlackRock (10/14/2025)Citigroup (10/14/2025)The Goldman Sachs Group (10/14/2025)Johnson & Johnson (10/14/2025)JPMorgan Chase & Co. (10/14/2025)Wells Fargo & Company (10/14/2025)ASML (10/15/2025)Abbott Laboratories (10/15/2025)Bank of America (10/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.